The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / January / Decoding RNA Expression in Cancer Data
Oncology Software and hardware Genetics and epigenetics Technology and innovation Molecular Pathology

Decoding RNA Expression in Cancer Data

New software links miRNA regulation with disease classification

01/23/2026 News 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll

Share

Clinical Scorecard: Decoding RNA Expression in Cancer Data

At a Glance

CategoryDetail
ConditionCancer
Key MechanismsInteractions between microRNAs (miRNAs) and messenger RNAs (mRNAs) in gene regulation.
Target PopulationPatients with various cancer types.
Care SettingResearch laboratories focusing on transcriptomic data.

Key Highlights

  • RNACOREX identifies disease-associated RNA regulatory networks.
  • Combines biological knowledge with patient expression data.
  • Achieves classification performance comparable to machine learning methods.
  • Provides interpretable visual representations of RNA interactions.
  • Highlights recurrent and tissue-specific RNA interactions.

Guideline-Based Recommendations

Diagnosis

  • Utilize RNACOREX for classifying patient samples based on gene expression data.

Management

  • Employ RNACOREX to prioritize candidate biomarkers or regulatory pathways.

Monitoring & Follow-up

  • Analyze RNA interactions to link expression patterns to clinical phenotypes.

Risks

  • RNACOREX is a research tool and does not establish clinical utility on its own.

Patient & Prescribing Data

Patients with RNA expression data from 13 cancer types.

Facilitates understanding of RNA regulation in disease for potential biomarker development.

Clinical Best Practices

  • Incorporate RNACOREX in research workflows for RNA expression analysis.
  • Use established databases to filter miRNA–mRNA interactions.

Related Resources & Content

  • PLOS Computational Biology

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.